Cholest-8(14)-enol is the major radioactive component of the 4-di-demethyl sterol fraction biosynthesized from 4,4-dimethyl[2-3H2]cholest-8(14)-enol by rat liver microsomal fractions, and therefore the first steps in the biosynthesis of cholesterol from the latter compound probably involve removal of the 4-methyl groups. 4,4-Dimethylcholesta-8,14-dienol therefore is not an intermediate in this process, although its presence in the incubation medium at a concentration of 0.146mM almost completely inhibits the demethylation of 4,4-dimethyl[2-3H2]cholest-8(14)-enol. Nor is cholesta-8,14-dienol an intermediate in the conversion of cholest-8(14)-enol into cholest-7-enol and cholesterol. With 4,4-dimethyl[2-3H2]cholesta-8,14-dienol as the cholesterol precursor, 4,4-dimethylcholest-8(9)-enol becomes heavily labelled and there is very little radioactivity associated with cholesta-8,14-dienol.In this case, the most heavily labelled 4-di-demethyl sterols are cholest-7-enol and cholesterol with the former predominating. There is little or no radioactivity associated with cholest-8(14)-enol. A similar labelling pattern amongst the 4-didemethyl sterols was observed with dihydro[14C]lanosterol as the precursor. The first step therefore in the synthesis of cholesterol from the 4,4-dimethyl[2-3H2]dienol is reduction of the A14(15) bond and not removal of the 4a-methyl group. Depending on the nature of the precursor, addition ofthe soluble fraction ofthe cell to the microsomal fraction resulted in a two-to four-fold stimulation of 4-di-demethyl sterol biosynthesis from the 4,4-dimethyl sterols studied. Under these conditions, 4,4-dimethylcholesta-8,14-dienol is the most efficient precursor of cholesterol and cholest-7-enol, and dihydrolanosterol is better than 4,4-dimethylcholest-8(14)-enol.
The mechanism and sequence of events by which the 14a-methyl group of lanosterol (compound Ia, Fig. 1 ) is removed are not completely established despite many recent investigations. It seems likely that the methyl carbon is eliminated as formic acid (Alexander etal., 1972) concomitant with the ultimate formation of a A8"14 diene or A8"14.24 triene (compound Ila or lIc, Fig. 1 ). The intermediacy of a A8(14) sterol of the type shown in Fig. 1 (structure III) in this process is a matter of controversy. Sterols of this type occur naturally (Lutsky & Schroepfer, 1969; Zalkow etal., 1968; Fioriti et al., 1970) and both structures lIla (Fried et al., 1968; Fiecchi et al., 1970; Paoletti et al., 1971) and IlIb (Lee et al., 1969b ; Lee & Schroepfer, 1968) are converted into cholesterol by cell-free systems. The reported formation of radioactive compound Ilb during cholesterol biosynthesis from labelled compound IlIb (Lutsky & Schroepfer, 1971) suggests the possibility of a biosynthetic sequence involving these compounds, at least at the 4-di-demethyl sterol level. However, at the 4,4-dimethyl sterol level, the stage at which the monoene-diene transformation should occur physiologically, although exogenously added non-radioVol. 144 active 4,4-dimethyldiene (compound Ila) 'traps' radioactivity from labelled dihydrolanosterol (compound Ib) (Fiecchi et al., 1969; Watkinson & Akhtar, 1969; Watkinson et al., 1971; Alexander et al., 1971) , the non-radioactive 4,4-dimethylmonoene (compound Illa) does not (Alexander et al., 1971; Fiecchi et al., 1972) . Nor does the addition ofnon-radioactive diene hIa result in an accumulation of radioactivity from the labelled monoene lIla (Fiecchi et al., 1970; Paoletti et al., 1971) , although these authors observed a large decrease in the formation of labelled cholesterol under these conditions. This observation, in itself, does not completely rule out the possibility that A8(14) sterols participate in cholesterol biosynthesis and requires further explanation. Also, the convertibility of A8(14) sterols into A8'14 sterols at the 4-di-demethyl level is difficult to reconcile with the above experiments at the 4,4-dimethyl sterol level. In an attempt to clarify this situation, and to assess the relative importance of structures Ila and Illa in the major pathway of cholesterol biosynthesis, the rates of methyl group loss and double-bond rearrangement, and the sequence with which these events occur during cholesterol synthesis from these 
Experimental

Methods
The preparation of cell-free systems, incubation procedures, isolation of the total lipid fraction, separation of 4,4-dimethyl sterols (lanosterol and companion C30 and C29 sterols) from 4-di-demethyl sterols (cholesterol and companion C27 sterols) and steroidal 3-ketones (t.l.c. on silica gel H in chloroform as the mobile phase, system 1), emulsification of sterol substrates, g.l.c., acetylation procedure and measurement of radioactivity have been described previously (Gibbons & Mitropoulos, 1973a,b) . The only deviation from these procedures is that incubations were conducted in flasks covered with Parafilm (Gallenkamp, London E.C.2, U.K.), with air as the gas phase. Unless otherwise stated, the incubation medium contained 1.2ml ofmicrosomal fraction, and, where appropriate, 3.0ml of S104 (the supernatant fraction obtained after spinning the Slo fraction for 1.Oh at lO5000gav.) in a total volume of 5.0ml. In each experiment, a zero-time control was carried out. This flask contained all the components of the incubated samples, but enzymic activity was destroyed immediately after addition of the substrate, by addition of a mixture of chloroform and methanol (2: 1, v/v). Immediately after incubation, appropriate carrier sterols were added to the mixture.
The components of the 4-di-demethyl sterol fraction were separated by acetylation and by chromatography on thin-layer plates of AgNO3-impregnated alumina (Gibbons et al., 1973) , with a mixture of toluene and hexane (1:3, v/v) mixture of toluene and hexane (1:1, v/v) as the moving phase (systems 2 and 4 respectively). Fractions containing 4,4-dimethylcholesta-8,14-dienol were isolated from the 4,4-dimethyl sterol fraction obtained after chromatography in system 1, by acetylation and further chromatography in system 2. After each chromatographic step in the purification procedures, portions of each fraction were removed for radioassay before further chromatography was undertaken.
Protein was measured by the method of Cleland & Slater (1953) .
Chemical syntheses
Non-radioactive 4,4-dimethylcholesta-5,7-dien-3-one, 4,4-dimethyl-5a-cholesta-8,14-dien-3,B-ol, 4,4-dimethyl-5a-cholest-8(14)-en-3fi-ol and 4,4-dimethyl5a-cholest-8(9)-en-3fl-ol were prepared as described previously (Gibbons & Mitropoulos, 1973a ).
5a-Cholesta-8,14-dien-3fl-ol. This was prepared by HCl isomerization of cholesta-5,7-dien-3fl-ol (4.0g) by the method of Fieser & Ourisson (1953) . Extraction followed by a threefold crystallization from methanol, gave 5a-cholesta-8,14-dien-3fl-ol (0.32g), maM., 250nm; 6250, 17100 litre mol-' cm'1; m.p., 114-115'C (m.p. 3-acetate, 97-99°C) . The reported physical constants for this material are: m.p., 116-117°C (m.p. 3-acetate, 99-100°C); )max. 250nm; 6250, 18100 litre -mol-' cm-' (Fieser & Ourisson, 1953 ).
5a-Cholest-8(14)-en-3fl-ol. Hydrogenation of a solution of cholesta-5,7-dienyl acetate (400mg) in acetic acid (75ml) in the presence of Adams catalyst (100mg) for 3 h at 11 8°C gave a material which had no u.v. absorption at 283 nm. Recrystallization of the product from a mixture of chloroform and methanol gave 5a-cholest-8(14)-enyl acetate (200mg), m.p., 74-76-C [reported, 77.5-78.5°C (Lee et al., 1969a) ]. G.l.c. on SE-30 showed the presence of only one peak with a relative retention time (cholesterol = 1) of 1.436. Alkaline hydrolysis of this material and two crystallizations from methanol gave 5ac-cholest-8(14)-en-3fl-ol, m.p., 118-120°C [reported, 120-121'C (Lee et al., 1969a) ].
4,4-Dimethyl-5a-[2-3H2]cholest-8(14)-en-3fl-ol. 4,4-Dimethyl-5a-cholest-8(14)-en-3fl-ol (51 mg, m.p. 143-144°C) was oxidized to the 3-ketone by the method of Djerassi et al. (1956) . The product showed only one band on t.l.c. (system 1) with an RF value of 0.67 (RF lanosterol, 0.42). Crystallization from methanol gave plates (31 mg), m.p. 94-960C [reported, 98-99°C (Fried & Brown, 1967) ]. I.r. analysis showed a strong band at 1706cm-' and a complete absence of absorption in the region 4000-3000cm-'. A portion of this Vol. 144 material (7.5mg) was dissolved in hexane (1.0ml) and applied to a column of basic alumina (3.0g, 160mmx7mm) which had been deactivated with tritiated water (0.2ml, 2.5 Ci/ml) and which had been allowed to equilibrate for 20h before the passage of 30ml ofhexane (Klein & Knight, 1965) . After application of the 3-ketone, the column was eluted with hexane (60ml), a mixture of ether and hexane (1.5:98.5, v/v; 20ml) , and finally, a further mixture ofether and hexane (3:97, v/v; 20ml) . Fractions of 2.Oml were taken during the chromatography and a portion of each fraction was taken for radioassay. The 4,4-dimethyl[2-3H2]enone was eluted in the fractions containing ether-hexane (1.5:98.5, v/v). These fractions were combined, and the solvent was evaporated to give a total radioactivity of 5.101 x 108d.p.m. To this material (7.8mg) was added non-radioactive 4,4-dimethyl-5a-cholest-8(14)-en-3-one (5.2mg); it was then reduced with a suspension of lithium aluminium hydride (60mg) in dry ether (7.0ml). After extraction and t.l.c. (system 1) only one band appeared with the same RF value as lanosterol. This contained 11.8mg (3.568 x 108 d.p.m.). After crystallization from methanol, the material weighed 8.51 mg (2.997 x 108d.p.m.). The compound was further purified by acetylation and t.l.c. in system 2. Only one band appeared which, after elution, hydrolysis, t.l.c. in system 1 and finally, crystallization from methanol yielded 3.37mg (1.307xl08d.p.m.), m.p., 143-144°C [reported, 142-143°C (Gautschi & Bloch, 1958) ].
4,4-Dimethyl-5-[2-3H2]cholesta-8,14-dien-3fl-ol.
4,4-Dimethylcholesta-5,7-dien-3-one (7.5mg) was tritiated in the same way as described above. The [2-3H2]dienone, eluted in the fractions containing ether-hexane (1.5:98.5, v/v), weighed 7.4mg (4.033 x 108d.p.m.). This was diluted with non-radioactive material (5.0mg) and reduced withlithium aluminium hydride as described above. The extracted product (3.355 x 108d.p.m.) was chromatographed in system 1 and the band with the same RF value as lanosterol was eluted (2.959 x 108d.p.m.). HCI isomerization of the [2-3H2]-dienol (Fieser & Ourisson, 1953) (Gibbons & Mitropoulos, 1973a,b (Table 1) , the fractions containing the 4,4-dimethyl sterols, steroidal-3-ketones and 4-didemethyl sterols were separated from the isolated total lipid material by t.l.c. in system 1, and a portion of each was removed for measurement of radioactivity. The radioactive components of each 4-didemethyl sterol fraction were separated by t.l.c. in system 3 after acetylation, and the distribution of radioactivity amongst these constituent sterols is shown in sta-8,14-dienol (Table 1) . However, cholest-7-enol was more highly labelled than cholesterol in each case. Addition of the appropriate non-radioactive steryl acetate to each radioactive fraction, obtained after chromatography of the 4-di-demethyl steryl acetate mixture in system 3, followed by recrystallization and measurement of specific radioactivity, showed that most of the radioactivity remained associated with these compounds (Table 2 ). In both types of incubation, less than 0.4% of the incubated radioactivity had the chromatographic mobility of A8(14) sterols, and this was probably due to contamination by the highly labelled cholest-7-enyl acetate fraction.
In a similar experiment, 4,4-dimethyl[2-3H2]-cholesta-8,14-dienol (1.343 x 106 d.p.m.; 97.1 nmol) was incubated with microsomal fraction (1.2ml) for 40min. The incubation was carried out in duplicate, and at the end of the incubation period 4,4-dimethylcholesta-8,14-dienol (2.0mg), 4,4-dimethylcholest-8(9)-enol (1.Omg), cholesta-8,14-dienol (2.0mg), cholesta-5,7-dienol (3.0mg), cholest-7-enol and cholest-8(14)-enol (0.5mg of each) were added and the radioactive 4,4-dimethyl and 4-di-demethyl sterols were isolated. After chromatography ofthe acetylated 4-di-demethyl sterol fraction (76350d.p.m. av.) in system 3, the dienic steryl acetates (29200d.p.m. av.) were rechromatographed in system 4. The isolated cholesta-8,14-dienyl acetate contained 16800d.p.m. (av.). To this material was added non-radioactive cholesta-8,14-dienyl acetate to give an initial specific radioactivity of 593d.p.m./mg, and the mixture was recrystallized four times. After an initial decrease, the specific radioactivity remained more or less constant after successive recrystallizations (255, 211, 220 and 214d.p.m./mg respectively). On the basis of the value for the final constant specific radioactivity therefore only 0.45 % of the incubated radioactivity was associated with cholesta-8,14-dienol. In contrast, chromatography of the acetylated 4,4-dimethyl sterol fraction (1.OOx 106 d.p.m. av.) in system 2 showed that 182300d.p.m. av. (13.57% of the incubated radioactivity) was associated with 4,4-dimethylcholest-8(9)-enyl acetate.
4,4-Dimethyl sterol metabolism by microsomal preparations in the presence of S104 fraction
To determine whether the distribution of radioactivity amongst the 4-di-demethyl sterol products of 4,4-dimethyl sterol metabolism was influenced by the presence of non-catalytic soluble carrier protein (Ritter & Dempsey, 1971; Scallen et al., 1971) , incubations were carried out with each of the labelled substrates in the presence and absence of the S104 fraction. The results of these experiments are presented in Table 3 , which shows that the rate of synthesis of the 4-di-demethyl sterols from all substrates is considerably increased in the presence of the S104 was the substrate, although the sum of the radioactivities of cholesterol and cholest-7-enol increased relative to that of cholest-8(14)-enol in the presence of S104, the latter sterol still contributed a large proportion to the total radioactivity of the 4-di-demethyl sterol fraction. 4,4-Dimethyl[2-3H2]cholesta-8,14-dienol in the presence of the microsomal preparation plus S104 was converted into 4-di-demethyl sterols at a greater rate (51.8 %) than was dihydro['4C]lanosterol (36.6 %), which itself was converted at a greater rate than was 4,4-dimethyl[2-3H2]cholest-8(14)-enol (17.6%, Table 3 ).
Effect of non-radioactive 4,4-dimethy1cholesta-8,14-dien-3,B-ol and cholesta-8,14-dien-3fl-ol on the rate of 4-di-demethyl sterol biosynthesis from 4,4-dimethyl-
Rat liver microsomal preparations were incubated in the presence of 4,4-dimethyl[2-3H2]cholest-8(14)-en-3/J-ol either alone or in the presence of relatively large amounts of non-radioactive 4,4-dimethylcholesta-8,14-dien-3fl-ol or cholesta-8,14-dienol. The residual radioactive 4,4-dimethyl sterol fraction was separated from the fractions containing 4-di-demethyl sterols and steroidal 3-ketones by t.l.c. in system 1. The constituents of each of the first two fractions were separated after acetylation followed by chromatography in systems 2 and 3 respectively. The cholesta-8,14-dienyl acetate so obtained after chromatography in system 3 was further purified by two successive chromatographic purifications in system 2. The results of this experiment are expressed in Table 4 . In the presence ofnon-radioactive 4,4-dimethylcholesta-8,14-dien-3,8-ol, the rate of synthesis of cholesterol and its 4-di-demethyl sterol precursors, cholest-7-enol and cholest-8(14)-en-3fl-ol, was substantially decreased and there was an increase in the radioactivity of the residual substrate. There was no increase in the amount of radioactivity associated with 4,4-dimethylcholesta-8,14-dien-3fl-ol. That the observed radioactivity of this fraction was not due to 4,4-dimethylcholesta-8,14-dien-3f8-ol has been demonstrated by the complete loss of radioactivity after addition of carrier material followed by several recrystallizations (see above (Ritter et al., 1972 ) that the metabolic sequence by which various precursors are converted into cholesterol may vary depending on the concentration ofnon-catalytic soluble carrier proteins (Ritter & Dempsey, 1971; Scallen et al., 1971) in the incubation medium. Although in the present case, supplementation of the microsomal fraction with the soluble fraction of the cell (S104) considerably increased the rate of cholesterol synthesis from the 4,4-dimethyl[2-3H2]monoene (structure lIla), cholest-8(14)-enol remained a predominant constituent of the 4-di-demethyl sterol fraction, suggesting that the soluble carrier proteins had no effect on the sequence of events. Under these circumstances, however, the concentration of cholest-7-en-3fl-ol, a known precursor of cholesterol, diminished relative to that of cholesterol itself, and a similar increase in the cholesterol/cholest-8(14)-en-3,l-ol ratio provides further evidence for the existence of a productprecursor relationship between the two. If this is the case, then the proportion ofradioactive cholesterol in the 4-di-demethyl sterol complex biosynthesized from the 4,4-dimethyl[2-3H2]monoene will depend on the activity of the enzymes and the length of incubation time. This may go some way towards explaining the apparent discrepancy between the work of Akhtar's group (Alexander et al., 1971) , who demonstrated that compound IIIa was a less efficient precursor of cholesterol than was dihydrolanosterol (Ib), an observation confirmed by the present work, and that of Fried et al. (1968) , who observed the opposite. The results of the latter authors are, however, ambiguous in any case, owing to the fact that the concentration ofthe incubated compound lb was very different from that of compound Illa.
In the presence of non-radioactive 4,4-dimethyldiene (Ha) the rate of biosynthesis of every 4-di- (Table 4) , and compound IIa itself did not accumulate radioactivity. This confinrns and extends previous observations in this respect (Paoletti et al., 1971) , but the present results demonstrate that, in view of the decrease in the concentration of the radioactive steroidal 3-ketone fraction (probably structure VIII, Scheme 1) and the increase in residual radioactive compound Illa under these circumstances, non-radioactive compound Ila exerts its inhibitory effect at the 4,4-dimethyl sterol-4a-demethylase stage, presumably by virtue of the 4,4-dimethyl grouping of compound IIa competing with that of compound IlIa for the demethylase enzymes. If cholest-8(14)-enol is an intermediate in the conversion of compound Illa into cholesterol, it seemed possible that cholesta-8,14-dien-3fi-ol (Ilb) may be involved in the rearrangement of the A8(14) bond to the A8 or A7 positions (Lutsky & Schroepfer, 1971) , However, addition of non-radioactive compound lIb to a microsomal system containing radioactive compound Illa decreased the rate of 4-di-demethyl sterol synthesis, but the ratio of cholest-8(14)-enol to cholest-7-enol did not increase, as would be expected owing to isotope dilution, if cholesta-8,14-dien-3fi-ol was an intermediate between the two. Nor did the latter sterol accumulate any measurable activity under these conditions. The mechanism of conversion of compound lIlb to compound XIII and/or compound XIV (Scheme 1) therefore remains unknown.
Cholesta-8,14-dien-3f6-ol is not In view of the efficient conversion of cholesta-8,14-dien-3fl-ol (compound IIb) into cholesterol by liver enzymes (Lutsky & Schroepfer, 1968 Canonica et al., 1968; Akhtar et al., 1968; Watkinson et al., 1971 ) and the formation of this compound during cholesterol biosynthesis from [2-14C]mevalonic acid by Chang liver cells (Wilton, 1971) , it was of interest to determine whether this was an obligatory physiological precursor ofcholesterol. However, the present results indicate that the first reaction in the metabolism of the 4,4-dimethyl[2-3H2]diene (compound Ila) to cholesterol is reduction of the A14 bond to give 4,4-dimethylcholest-8(9)-enol (compound IV) and not removal of the methyl groups to give compound Ilb (Scheme 1). This was evidenced by the relative amounts of these compounds isolated after metabolism of compound Ila in which 13.57 and 0.45 % of the incubated radioactivity was associated with compounds IV and Ilb respectively. This is consistent with the postulated sequence by which lanosterol is converted into cholesterol and in the present work the radioactivity distribution pattern amongst the 4-di-demethyl sterol products of dihydro[(4C]lanosterol metabolism was very similar to that observed when the 4,4-dimethyl[2-3H2]diene (structure Ila) was the precursor, regardless of whether the microsomal preparation alone, or microsomal preparation plus S104 were used (Table 3) Cholesterol and cholest-7-enol in the presence of microsomal preparations plus S104 were formed in relatively small amounts (3.9 and 6.2 % respectively, Table 3 ) from 4,4-dimethyl[2-3H2]cholest-8(14)-en3fl-ol owing, at least in part, to the apparent difficulty of isomerization of the A8 (14) 
